{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:33:31Z","timestamp":1788831211383,"version":"build-2803163510"},"reference-count":208,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1684\/bdc.2013.1826","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"266-282","source":"Crossref","is-referenced-by-count":1,"title":["Vitamine D et cancer du sein : physiopathologie, implications biologiques et cliniques"],"prefix":"10.1016","volume":"101","author":[{"given":"Nelly","family":"Firmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Romieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2013.1826_bib0005","article-title":"The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends","author":"Guerin","year":"2009","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","article-title":"Global vitamin D status and determinants of hypovitaminosis D","volume":"20","author":"Mithal","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1684\/bdc.2013.1826_bib0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1359\/jbmr.081209","article-title":"Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective","volume":"24","author":"Kuchuk","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1684\/bdc.2013.1826_bib0020","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1245\/s10434-012-2297-3","article-title":"The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.","volume":"19","author":"Peppone","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/jcp.2006.042747","article-title":"Serum 25-hydroxyvitamin D levels in early and advanced breast cancer","volume":"59","author":"Palmieri","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1684\/bdc.2013.1826_bib0030","doi-asserted-by":"crossref","unstructured":"Jacot W, Pouderoux S, Thezenas S, et al. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 134 : 709-17.","DOI":"10.1007\/s10549-012-2084-7"},{"key":"10.1684\/bdc.2013.1826_bib0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1055-9965.EPI-07-2594","article-title":"Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"17","author":"Freedman","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0040","doi-asserted-by":"crossref","unstructured":"Prieto-Alhambra D, Javaid MK, Servitja S, et al. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res Treat 125 : 869-78.","DOI":"10.1007\/s10549-010-1075-9"},{"key":"10.1684\/bdc.2013.1826_bib0045","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1200\/JCO.2008.20.8629","article-title":"Vitamin D in cancer patients: above all, do no harm","volume":"27","author":"Goodwin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0050","unstructured":"Afssa. Les apports nutritionnels conseill\u00e9s pour la population fran\u00e7aise. Cachan : \u00e9ditions Lavoisier, 2001 (ed. \u00e8. \u00e9dition)."},{"key":"10.1684\/bdc.2013.1826_bib0055","unstructured":"Inra. R\u00e9pertoire g\u00e9n\u00e9ral des aliments. Table de composition. Paris : \u00e9ditions Inra, 1995 (ed. \u00e8. \u00e9dition)."},{"key":"10.1684\/bdc.2013.1826_bib0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","article-title":"Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin","volume":"67","author":"Webb","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0070","first-page":"4125","article-title":"Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population","volume":"85","author":"Harris","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2133.1982.tb00357.x","article-title":"Tanning, protection against sunburn and vitamin D formation with a UV-A \u2018sun-bed\u2019","volume":"107","author":"Devgun","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1684\/bdc.2013.1826_bib0080","first-page":"1129","article-title":"Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group","volume":"81","author":"Chapuy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","article-title":"Increased skin pigment reduces the capacity of skin to synthesise vitamin D3","volume":"1","author":"Clemens","year":"1982","journal-title":"Lancet"},{"key":"10.1684\/bdc.2013.1826_bib0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/jc.2007-1217","article-title":"Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men","volume":"93","author":"Hannan","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcn\/85.1.124","article-title":"A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern United States","volume":"85","author":"Willis","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4065\/81.3.353","article-title":"High prevalence of vitamin D inadequacy and implications for health","volume":"81","author":"Holick","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1684\/bdc.2013.1826_bib0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0110","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"10.1684\/bdc.2013.1826_bib0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/mol.109.056986","article-title":"Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b","volume":"76","author":"Komagata","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1684\/bdc.2013.1826_bib0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"key":"10.1684\/bdc.2013.1826_bib0130","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2013.1826_bib0135","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1073\/pnas.231474698","article-title":"Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects","volume":"98","author":"Van Cromphaut","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2013.1826_bib0140","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/mend.16.7.0866","article-title":"Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D","volume":"16","author":"Erben","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199803053381010","article-title":"The many faces of rickets","volume":"338","author":"Bouillon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0150","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","article-title":"Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"key":"10.1684\/bdc.2013.1826_bib0155","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2013.1826_bib0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00003.2004","article-title":"Calcium absorption across epithelia","volume":"85","author":"Hoenderop","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1684\/bdc.2013.1826_bib0165","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/jama.294.18.2336","article-title":"Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake","volume":"294","author":"Steingrimsdottir","year":"2005","journal-title":"Jama"},{"key":"10.1684\/bdc.2013.1826_bib0170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/07315724.2003.10719287","article-title":"Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D","volume":"22","author":"Heaney","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(99)00460-X","article-title":"Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption","volume":"108","author":"Basha","year":"2000","journal-title":"Am J Med"},{"key":"10.1684\/bdc.2013.1826_bib0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1684\/bdc.2013.1826_bib0185","doi-asserted-by":"crossref","unstructured":"Bischoff-Ferrari HA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367 : 40-9.","DOI":"10.1056\/NEJMoa1109617"},{"key":"10.1684\/bdc.2013.1826_bib0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1359\/jbmr.2004.19.2.265","article-title":"Vitamin D receptor expression in human muscle tissue decreases with age","volume":"19","author":"Bischoff-Ferrari","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1684\/bdc.2013.1826_bib0195","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ajcn\/80.3.752","article-title":"Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged>or =60 y","volume":"80","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1532-5415.2007.01048.x","article-title":"A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study","volume":"55","author":"Broe","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1684\/bdc.2013.1826_bib0205","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/diabetes.49.8.1301","article-title":"1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1\/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)","volume":"49","author":"Overbergh","year":"2000","journal-title":"Diabetes"},{"key":"10.1684\/bdc.2013.1826_bib0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1172\/JCI0212392","article-title":"Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice","volume":"109","author":"O\u2019Kelly","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1684\/bdc.2013.1826_bib0215","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diabetes.49.3.504","article-title":"Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans","volume":"49","author":"Pani","year":"2000","journal-title":"Diabetes"},{"key":"10.1684\/bdc.2013.1826_bib0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1470635","article-title":"Vitamin D receptor genotype is associated with Addison's disease","volume":"147","author":"Pani","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0225","first-page":"4639","article-title":"Vitamin D receptor gene polymorphism is associated with Graves\u2019 disease in the Japanese population","volume":"85","author":"Ban","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0230","first-page":"1704S","article-title":"Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions","volume":"125","author":"Lemire","year":"1995","journal-title":"J Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0235","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"10.1684\/bdc.2013.1826_bib0240","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2013.1826_bib0245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916939209150321","article-title":"1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice","volume":"12","author":"Lemire","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1684\/bdc.2013.1826_bib0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jn\/128.1.68","article-title":"1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis","volume":"128","author":"Cantorna","year":"1998","journal-title":"J Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0255","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","article-title":"Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3","volume":"37","author":"Mathieu","year":"1994","journal-title":"Diabetologia"},{"key":"10.1684\/bdc.2013.1826_bib0260","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00125-004-1329-3","article-title":"Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice","volume":"47","author":"Giulietti","year":"2004","journal-title":"Diabetologia"},{"key":"10.1684\/bdc.2013.1826_bib0265","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcb.10347","article-title":"Vitamin D and autoimmune diabetes","volume":"88","author":"Zella","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1684\/bdc.2013.1826_bib0270","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","article-title":"A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases","volume":"17","author":"Froicu","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0275","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"key":"10.1684\/bdc.2013.1826_bib0280","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s001250051499","article-title":"Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring","volume":"43","author":"Stene","year":"2000","journal-title":"Diabetologia"},{"key":"10.1684\/bdc.2013.1826_bib0285","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"Jama"},{"key":"10.1684\/bdc.2013.1826_bib0290","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-125-5-199609010-00001","article-title":"Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study","volume":"125","author":"McAlindon","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1684\/bdc.2013.1826_bib0295","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1684\/bdc.2013.1826_bib0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/endo.139.1.5641","article-title":"Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A","volume":"139","author":"Casteels","year":"1998","journal-title":"Endocrinology"},{"key":"10.1684\/bdc.2013.1826_bib0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1684\/bdc.2013.1826_bib0310","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","volume":"279","author":"Aihara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0315","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension","volume":"49","author":"Forman","year":"2007","journal-title":"Hypertension"},{"key":"10.1684\/bdc.2013.1826_bib0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","article-title":"Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey","volume":"20","author":"Scragg","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1684\/bdc.2013.1826_bib0325","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1684\/bdc.2013.1826_bib0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1684\/bdc.2013.1826_bib0335","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s001250050685","article-title":"Vitamin D, glucose tolerance and insulinaemia in elderly men","volume":"40","author":"Baynes","year":"1997","journal-title":"Diabetologia"},{"key":"10.1684\/bdc.2013.1826_bib0340","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"92","article-title":"Vitamin D: photobiology, metabolism, mechanism of action and clinical applications","author":"Holick","year":"1999"},{"key":"10.1684\/bdc.2013.1826_bib0345","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1684\/bdc.2013.1826_bib0350","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1684\/bdc.2013.1826_bib0355","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.10.2.142","article-title":"Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937","volume":"10","author":"Liu","year":"1996","journal-title":"Genes Dev"},{"key":"10.1684\/bdc.2013.1826_bib0360","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood.V93.7.2225","article-title":"1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1\/CIP1) and p27(KIP1)","volume":"93","author":"Muto","year":"1999","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1826_bib0365","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/nar\/gki502","article-title":"Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter","volume":"33","author":"Sinkkonen","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1684\/bdc.2013.1826_bib0370","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/bbrc.1993.1604","article-title":"Differential modulation of fos and jun gene expression by 1,25-dihydroxyvitamin D3","volume":"193","author":"Tu-Yu","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1684\/bdc.2013.1826_bib0375","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.283.5406.1317","article-title":"Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators","volume":"283","author":"Yanagisawa","year":"1999","journal-title":"Science"},{"key":"10.1684\/bdc.2013.1826_bib0380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-55580-0_2","article-title":"Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands","volume":"164","author":"Carlberg","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0385","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/jn\/135.10.2350","article-title":"Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb\/c mice","volume":"135","author":"Tangpricha","year":"2005","journal-title":"J Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0390","first-page":"4057","article-title":"Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3","volume":"54","author":"Shabahang","year":"1994","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0400","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.87.3.214","article-title":"1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo","volume":"87","author":"Mantell","year":"2000","journal-title":"Circ Res"},{"key":"10.1684\/bdc.2013.1826_bib0405","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0960-0760(96)00055-6","article-title":"1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells","volume":"58","author":"Simboli-Campbell","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1684\/bdc.2013.1826_bib0410","doi-asserted-by":"crossref","unstructured":"Blomberg Jensen M, Andersen CB, Nielsen JE, et al. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer. J Steroid Biochem Mol Biol 121 : 376-82.","DOI":"10.1016\/j.jsbmb.2010.03.069"},{"key":"10.1684\/bdc.2013.1826_bib0415","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0278-6915(02)00030-3","article-title":"Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress","volume":"40","author":"Kallay","year":"2002","journal-title":"Food Chem Toxicol"},{"key":"10.1684\/bdc.2013.1826_bib0420","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/1471-2164-10-499","article-title":"Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down","volume":"10","author":"Costa","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1684\/bdc.2013.1826_bib0425","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0430","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/bbrc.1994.1714","article-title":"Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors","volume":"201","author":"Dormanen","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1684\/bdc.2013.1826_bib0435","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1016\/S0021-9258(20)80689-9","article-title":"Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3","volume":"268","author":"Norman","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0440","first-page":"1370","article-title":"Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery","volume":"15","author":"Jensen","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(98)00117-8","article-title":"Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells","volume":"142","author":"Verlinden","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0145-2126(95)00122-0","article-title":"Down regulation of NM23.H1 NM23.H2, and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3","volume":"20","author":"Caligo","year":"1996","journal-title":"Leuk Res"},{"key":"10.1684\/bdc.2013.1826_bib0455","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.190.11.1583","article-title":"1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex","volume":"190","author":"Hmama","year":"1999","journal-title":"J Exp Med"},{"key":"10.1684\/bdc.2013.1826_bib0460","first-page":"7799","article-title":"Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells","volume":"63","author":"Palmer","year":"2003","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0465","first-page":"1127","article-title":"Regulation of gene expression by 1alpha,25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells","volume":"15","author":"Akutsu","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1684\/bdc.2013.1826_bib0470","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcb.20182","article-title":"Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells","volume":"93","author":"Guzey","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1684\/bdc.2013.1826_bib0475","doi-asserted-by":"crossref","first-page":"35505","DOI":"10.1074\/jbc.274.50.35505","article-title":"1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent Caco-2 cell differentiation","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0480","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1038\/sj.onc.1208801","article-title":"1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells","volume":"24","author":"Fernandez-Garcia","year":"2005","journal-title":"Oncogene"},{"key":"10.1684\/bdc.2013.1826_bib0485","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","article-title":"Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling","volume":"154","author":"Palmer","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1684\/bdc.2013.1826_bib0490","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0083-6729(02)64010-5","article-title":"Antiproliferative action of vitamin D","volume":"64","author":"Ylikomi","year":"2002","journal-title":"Vitam Horm"},{"key":"10.1684\/bdc.2013.1826_bib0495","doi-asserted-by":"crossref","first-page":"26365","DOI":"10.1074\/jbc.M010101200","article-title":"Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1","volume":"276","author":"McGuire","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0500","doi-asserted-by":"crossref","first-page":"53213","DOI":"10.1074\/jbc.M410395200","article-title":"Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase","volume":"279","author":"Jiang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0505","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1158\/0008-5472.CAN-06-0905","article-title":"Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0510","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI114097","article-title":"Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries","volume":"83","author":"Merke","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1684\/bdc.2013.1826_bib0515","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q","article-title":"Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats","volume":"81","author":"Iseki","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0520","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1074\/jbc.M608894200","article-title":"Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol","volume":"282","author":"Chung","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0525","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/carcin\/bgl041","article-title":"1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis","volume":"27","author":"Bao","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1684\/bdc.2013.1826_bib0530","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/sj.onc.1203888","article-title":"The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression","volume":"19","author":"Campbell","year":"2000","journal-title":"Oncogene"},{"key":"10.1684\/bdc.2013.1826_bib0535","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jsbmb.2006.09.014","article-title":"Vitamin D and cancer","volume":"102","author":"Bouillon","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1684\/bdc.2013.1826_bib0540","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/carcin\/23.12.2103","article-title":"Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis","volume":"23","author":"Zinser","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1684\/bdc.2013.1826_bib0545","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsbmb.2005.06.024","article-title":"Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues","volume":"97","author":"Zinser","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1684\/bdc.2013.1826_bib0550","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/carcin\/bgh271","article-title":"Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice","volume":"25","author":"Zinser","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1684\/bdc.2013.1826_bib0555","first-page":"821","article-title":"Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression","volume":"1","author":"Hershberger","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1684\/bdc.2013.1826_bib0560","first-page":"3759","article-title":"Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system","volume":"57","author":"Light","year":"1997","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0565","first-page":"695","article-title":"1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines","volume":"5","author":"Moffatt","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0570","first-page":"1043","article-title":"Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis","volume":"7","author":"Hershberger","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0575","first-page":"2040","article-title":"1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0580","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002800000251","article-title":"The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells","volume":"47","author":"Chaudhry","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1684\/bdc.2013.1826_bib0585","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1006123819675","article-title":"Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo.","volume":"53","author":"Koshizuka","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1684\/bdc.2013.1826_bib0590","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0091-7435(90)90058-R","article-title":"Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation","volume":"19","author":"Garland","year":"1990","journal-title":"Prev Med"},{"key":"10.1684\/bdc.2013.1826_bib0595","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G","article-title":"Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation","volume":"70","author":"Hanchette","year":"1992","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0600","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/9.3.227","article-title":"Do sunlight and vitamin D reduce the likelihood of colon cancer?","volume":"9","author":"Garland","year":"1980","journal-title":"Int J Epidemiol"},{"key":"10.1684\/bdc.2013.1826_bib0605","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cncr.10427","article-title":"An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation","volume":"94","author":"Grant","year":"2002","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0610","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.HP.0000137179.03423.0b","article-title":"Ecological study of solar radiation and cancer mortality in Japan","volume":"87","author":"Mizoue","year":"2004","journal-title":"Health Phys"},{"key":"10.1684\/bdc.2013.1826_bib0615","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jnci\/djj101","article-title":"Prospective study of predictors of vitamin D status and cancer incidence and mortality in men","volume":"98","author":"Giovannucci","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2013.1826_bib0620","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(89)91789-3","article-title":"Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study","volume":"2","author":"Garland","year":"1989","journal-title":"Lancet"},{"key":"10.1684\/bdc.2013.1826_bib0625","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/1055-9965.1502.13.9","article-title":"Plasma vitamin D metabolites and risk of colorectal cancer in women","volume":"13","author":"Feskanich","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0630","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jnci\/djm204","article-title":"Prospective study of serum vitamin D and cancer mortality in the United States","volume":"99","author":"Freedman","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2013.1826_bib0635","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1008923802001","article-title":"Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)","volume":"11","author":"Ahonen","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1684\/bdc.2013.1826_bib0640","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1055-9965.EPI-06-0206","article-title":"Vitamin D intake and the risk for pancreatic cancer in two cohort studies","volume":"15","author":"Skinner","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0645","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.2006.07.5358","article-title":"Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients","volume":"25","author":"Zhou","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0650","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Lappe","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0655","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","article-title":"Calcium plus vitamin D supplementation and the risk of colorectal cancer","volume":"354","author":"Wactawski-Wende","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0660","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1200\/JCO.2008.20.0725","article-title":"Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer","volume":"27","author":"Goodwin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0665","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2008.19.6162","article-title":"High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy","volume":"27","author":"Crew","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0670","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1200\/JCO.2008.20.2549","article-title":"Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance","volume":"27","author":"Mann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0675","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9343(02)01091-4","article-title":"Vitamin D insufficiency among free-living healthy young adults","volume":"112","author":"Tangpricha","year":"2002","journal-title":"Am J Med"},{"key":"10.1684\/bdc.2013.1826_bib0680","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/75985","article-title":"Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene","volume":"25","author":"Albertson","year":"2000","journal-title":"Nat Genet"},{"key":"10.1684\/bdc.2013.1826_bib0685","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0690","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0695","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/carcin\/bgm240","article-title":"Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer \u2013 results of a large case-control study","volume":"29","author":"Abbas","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1684\/bdc.2013.1826_bib0700","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr1994","article-title":"Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk","volume":"10","author":"Abbas","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0705","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jsbmb.2006.12.007","article-title":"Vitamin D and prevention of breast cancer: pooled analysis","volume":"103","author":"Garland","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1684\/bdc.2013.1826_bib0710","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S1368980099000385","article-title":"Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk","volume":"2","author":"Janowsky","year":"1999","journal-title":"Public Health Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0715","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/1055-9965.EPI-04-0722","article-title":"Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer","volume":"14","author":"Bertone-Johnson","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0720","doi-asserted-by":"crossref","unstructured":"Chen P, Li M, Gu X, et al. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS One 8 : e49312.","DOI":"10.1371\/journal.pone.0049312"},{"key":"10.1684\/bdc.2013.1826_bib0725","doi-asserted-by":"crossref","unstructured":"Amir E, Cecchini RS, Ganz PA, et al. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133 : 1077-88.","DOI":"10.1007\/s10549-012-2012-x"},{"key":"10.1684\/bdc.2013.1826_bib0730","doi-asserted-by":"crossref","unstructured":"Edvardsen K, Veierod MB, Brustad M, et al. Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int J Cancer 128 : 1425-33.","DOI":"10.1002\/ijc.25463"},{"key":"10.1684\/bdc.2013.1826_bib0735","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2356","article-title":"Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort","volume":"11","author":"McCullough","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1684\/bdc.2013.1826_bib0740","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1158\/1055-9965.EPI-08-0539","article-title":"Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium","volume":"18","author":"McKay","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0745","doi-asserted-by":"crossref","unstructured":"Bertone-Johnson ER, McTiernan A, Thomson CA, et al. Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial. Cancer Epidemiol Biomarkers Prev 21 : 462-73.","DOI":"10.1158\/1055-9965.EPI-11-1009"},{"key":"10.1684\/bdc.2013.1826_bib0750","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/1055-9965.EPI-05-0068","article-title":"Vitamin D and calcium intakes from food or supplements and mammographic breast density","volume":"14","author":"Berube","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2013.1826_bib0755","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10549-008-0213-0","article-title":"A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease","volume":"116","author":"Rohan","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1684\/bdc.2013.1826_bib0760","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/jnci\/djn360","article-title":"Calcium plus vitamin D supplementation and the risk of breast cancer","volume":"100","author":"Chlebowski","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2013.1826_bib0765","doi-asserted-by":"crossref","unstructured":"Jacobs ET, Thomson CA, Flatt SW, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) study. Am J Clin Nutr 93 : 108-17.","DOI":"10.3945\/ajcn.2010.30009"},{"key":"10.1684\/bdc.2013.1826_bib0770","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10552-007-9020-x","article-title":"Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study","volume":"18","author":"Robien","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1684\/bdc.2013.1826_bib0775","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.4076\/1757-1626-2-8390","article-title":"Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series","volume":"2","author":"Rainville","year":"2009","journal-title":"Cases J"},{"key":"10.1684\/bdc.2013.1826_bib0780","unstructured":"Nagykalnai T, Landherr L, Meszaros E. Aromatase inhibitors and arthralgia. Magy Onkol 55 : 32-9."},{"key":"10.1684\/bdc.2013.1826_bib0785","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1684\/bdc.2013.1826_bib0790","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0795","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0800","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0805","doi-asserted-by":"crossref","unstructured":"Younus M, et al. Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature. Drug Saf 34 : 1125-49.","DOI":"10.2165\/11594170-000000000-00000"},{"key":"10.1684\/bdc.2013.1826_bib0810","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.ejca.2006.07.005","article-title":"Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study","volume":"42","author":"Geisler","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0815","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer","volume":"23","author":"Lonning","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0820","doi-asserted-by":"crossref","unstructured":"Prieto-Alhambra D, et al. Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. Breast Cancer Res Treat 133 : 1159-67.","DOI":"10.1007\/s10549-012-2013-9"},{"key":"10.1684\/bdc.2013.1826_bib0825","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0830","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","article-title":"Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer","volume":"26","author":"Partridge","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0835","doi-asserted-by":"crossref","unstructured":"Khan QJ, et al. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119 : 111-8.","DOI":"10.1007\/s10549-009-0495-x"},{"issue":"4 Suppl. 9","key":"10.1684\/bdc.2013.1826_bib0840","first-page":"10","article-title":"Aromatase inhibitors and breast cancer","volume":"23","author":"Brodie","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1684\/bdc.2013.1826_bib0845","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02555109","article-title":"The effect of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D","volume":"39","author":"Buchanan","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1684\/bdc.2013.1826_bib0850","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjmed.2003.12.029","article-title":"Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults","volume":"116","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am J Med"},{"key":"10.1684\/bdc.2013.1826_bib0855","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"Jama"},{"key":"10.1684\/bdc.2013.1826_bib0860","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1684\/bdc.2013.1826_bib0865","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of vitamin D on falls: a meta-analysis","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"Jama"},{"key":"10.1684\/bdc.2013.1826_bib0870","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1207\/S15327914nc391_5","article-title":"Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk","volume":"39","author":"Levine","year":"2001","journal-title":"Nutr Cancer"},{"key":"10.1684\/bdc.2013.1826_bib0875","unstructured":"Vitamin D and cancer. Proceedings of the vitamin D workshop meeting. November 17-19, 2004. National Institutes of Health, Bethesda, Maryland, USA. J Steroid Biochem Mol Biol 2005 ; 97 : 1-218."},{"key":"10.1684\/bdc.2013.1826_bib0880","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2013.1826_bib0885","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","article-title":"Vitamin D status: measurement, interpretation, and clinical application","volume":"19","author":"Holick","year":"2009","journal-title":"Ann Epidemiol"},{"key":"10.1684\/bdc.2013.1826_bib0890","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2005.06.020","article-title":"The vitamin D requirement in health and disease","volume":"97","author":"Heaney","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1684\/bdc.2013.1826_bib0895","doi-asserted-by":"crossref","unstructured":"Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95 : 1357-64.","DOI":"10.3945\/ajcn.111.031070"},{"key":"10.1684\/bdc.2013.1826_bib0900","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0905","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/jc.2008-0350","article-title":"Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly","volume":"93","author":"Romagnoli","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0910","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0915","first-page":"407","article-title":"Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women","volume":"1","author":"Tjellesen","year":"1986","journal-title":"Bone Miner"},{"key":"10.1684\/bdc.2013.1826_bib0920","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03009740802419081","article-title":"The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency","volume":"38","author":"Leventis","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1684\/bdc.2013.1826_bib0925","doi-asserted-by":"crossref","unstructured":"Binkley N, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 96 : 981-8.","DOI":"10.1210\/jc.2010-0015"},{"key":"10.1684\/bdc.2013.1826_bib0930","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bone.2009.07.015","article-title":"Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol","volume":"45","author":"Glendenning","year":"2009","journal-title":"Bone"},{"key":"10.1684\/bdc.2013.1826_bib0935","doi-asserted-by":"crossref","unstructured":"Heaney RP, et al. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 96 : E447-52.","DOI":"10.1210\/jc.2010-2230"},{"key":"10.1684\/bdc.2013.1826_bib0940","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0945","doi-asserted-by":"crossref","unstructured":"Biancuzzo RM, et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 91 : 1621-6.","DOI":"10.3945\/ajcn.2009.27972"},{"key":"10.1684\/bdc.2013.1826_bib0950","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1016\/S0021-9258(18)67647-1","article-title":"24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process","volume":"261","author":"Horst","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1684\/bdc.2013.1826_bib0955","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3109\/00365518609084051","article-title":"25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3","volume":"46","author":"Holmberg","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1684\/bdc.2013.1826_bib0960","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/07315724.1999.10718885","article-title":"Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU\/day of vitamin D","volume":"18","author":"Harris","year":"1999","journal-title":"J Am Coll Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0965","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jps.2600690932","article-title":"Stability of solid drugs: degradation of ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) at high humidities and elevated temperatures","volume":"69","author":"Grady","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1684\/bdc.2013.1826_bib0970","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ajcn\/73.2.288","article-title":"Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level","volume":"73","author":"Vieth","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0975","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00198-007-0465-2","article-title":"Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents","volume":"19","author":"Chel","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1684\/bdc.2013.1826_bib0980","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/jc.2008-0241","article-title":"Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients","volume":"93","author":"Ish-Shalom","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib0985","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ajcn\/87.3.688","article-title":"Pharmacokinetics of a single, large dose of cholecalciferol","volume":"87","author":"Ilahi","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0990","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib0995","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1185\/030079908X301857","article-title":"New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion","volume":"24","author":"Roux","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1684\/bdc.2013.1826_bib1000","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00198-006-0293-9","article-title":"How to select the doses of vitamin D in the management of osteoporosis","volume":"18","author":"Bischoff-Ferrari","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1684\/bdc.2013.1826_bib1005","unstructured":"Suitor CW, Meyers LD, Institute of Medicine (U.S.), Food and Nutrition Board. Dietary reference intakes research synthesis workshop summary. 2007 (cited ; 1 online resource [xii, 297 p.])."},{"key":"10.1684\/bdc.2013.1826_bib1010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ajcn\/85.3.649","article-title":"The urgent need to recommend an intake of vitamin D that is effective","volume":"85","author":"Vieth","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib1015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcn\/85.1.6","article-title":"Risk assessment for vitamin D","volume":"85","author":"Hathcock","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1684\/bdc.2013.1826_bib1020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1359\/jbmr.2003.18.7.1342","article-title":"Vitamin D depletion and effective calcium absorption","volume":"18","author":"Heaney","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1684\/bdc.2013.1826_bib1025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/jc.2002-021064","article-title":"Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D","volume":"88","author":"Vieth","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib1030","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2006-1404","article-title":"Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials","volume":"92","author":"Boonen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1684\/bdc.2013.1826_bib1035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lpm.2008.08.008","article-title":"Vitamin D: skeletal and extra skeletal effects; recommendations for good practice","volume":"38","author":"Briot","year":"2009","journal-title":"Presse Med"},{"key":"10.1684\/bdc.2013.1826_bib1040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1515\/CCLM.2009.036","article-title":"Vitamin D: current status and perspectives","volume":"47","author":"Cavalier","year":"2009","journal-title":"Clin Chem Lab Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115301211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115301211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T16:15:22Z","timestamp":1664122522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115301211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":208,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0007455115301211"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2013.1826","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}